Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593592 | SCV000709304 | uncertain significance | not provided | 2017-06-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001323562 | SCV001514482 | uncertain significance | Imerslund-Grasbeck syndrome | 2021-07-12 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with alanine at codon 1357 of the CUBN protein (p.Pro1357Ala). The proline residue is moderately conserved and there is a small physicochemical difference between proline and alanine. This variant is present in population databases (rs780012075, ExAC 0.01%). This variant has not been reported in the literature in individuals with CUBN-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002476340 | SCV002780736 | uncertain significance | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2022-04-23 | criteria provided, single submitter | clinical testing |